Earnings NewsHealthcareAcasti Pharma reports FQ4 resultsMay 25, 2016 5:09 PM ETAcasti Pharma Inc. (ACST) Stock, ACST:CA StockBy: SA News Team Acasti Pharma (NASDAQ:ACST): FQ4 EPS of -$0.18 Revenue of $21K (-88.2% Y/Y). Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgACSTACST--ACST:CAACST:CA--1D5D1M6M1Y5Y10YCompareTrending AnalysisTrending News